A Comparison of Scar Infiltration, Scar Deactivation, and Standard of Care for the Treatment of Chronic, Post-Surgical Pain After Cesarean Section
CompletedNot applicableNCT03936309
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
To compare scar infiltration with 0.5-1% Lidocaine at a dose of 3 mg/kg (max dose 300 mg) or scar deactivation with acupuncture surface release technique to determine which is more effective in reducing pain in adult patients with chronic, post-surgical pain related to the site of incision after low transverse Cesarean section compared to standard of care physical therapy with the McKenzie Method.
Study details
- Official title
- A Comparison of Scar Infiltration, Scar Deactivation, and Standard of Care for the Treatment of Chronic, Post-Surgical Pain After Cesarean Section in the Primary Care Setting: A Comparative Effectiveness Trial.
- Conditions
- Scar
- Cesarean Section
- Dehiscence
- Interventions
- Other: Scar Deactivation Surface Release Technique protocol
- Other: Scar Infiltration with 0.25-1% Lidocaine
- Other: Physical therapy
- Sponsor
- Jennifer Loomis
- Collaborators
- Mike O'Callaghan Military Hospital
- Organization
- 375th Medical Group, Scott Air Force Base
- Start date
- 2019-06-01
- Primary completion
- 2025-04-08
- Sex
- Female
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
\*\*Patients must be able to get care at Nellis Air Force Base or Scott AFB (a military installation) in order to participate in this study.\*\* Inclusion Criteria: * Female DoD beneficiaries age 18 years or older * 3 months or greater postpartum with abdominal and/or back pain starting after low transverse Cesarean section scar. * If subject has had prior Scar Deactivation with Surface Release Technique for cesarean section scar they must have completed a washout period of 12 weeks or more. Exclusion Criteria: * Pregnant * Prior Scar Deactivation with Surface Release Technique for cesarean section scar within the last 12 weeks. * Ever had Prior Scar Infiltration with Lidocaine for cesarean section. * Active cellulitis surrounding scar * Revision of Cesarean section scar * Vertical incision or emergent Cesarean section
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03936309